Back to search

Peptide record

TPDB41462

ALA-A2 Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41462
ALA-A2
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 13-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
KLWCKSSQVPQSR
Physicochemical Analysis
C67H111N21O19S1
ANDEGHIMFTY
S
1546.81
10.59
3
0
3
+3
2.21
-1.054
52.31
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
5500
355.57
6
Residue Composition
number
0
A
1
R
0
N
0
D
1
C
0
E
2
Q
0
G
0
H
0
I
1
L
2
K
0
M
0
F
1
P
3
S
0
T
1
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 1 E: 0 Q: 2 G: 0 H: 0 I: 0 L: 1 K: 2 M: 0 F: 0 P: 1 S: 3 T: 0 W: 1 Y: 0 V: 1
Chemical Descriptors
13
C67H111N21O19S1
1546.81
10.59
+3
2.21
-1.054
Free
L
Linear
Free
Anticancer
Alpha-Lactalbumin
Evidence Records 2 records
Evidence 1 Activity

Activity

~50% cell viability
Anticancer

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

~50% cell viability
Anticancer

Target

Colon Cancer
HT-29
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023